← Search

Data · dataset · 2025

NCT04013854 Neoadjuvant anti-PD-1 Nivolumab Clinical Trial (To Patient 67)

Listed in Teesside University Research Data Repository

Flow cytometry data for NCT04013854 Neoadjuvant anti-PD-1 Nivolumab Clinical Trial.

Description

Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with pathologic response to neoadjuvant anti-PD-1 therapy Cancer Cell 2025

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Cancer 75%
Provenance · 1 source records, 7 field assertions
SourceKeyLast seenRaw
Teesside University Research Data Repositoryoai:data.mendeley.com/kytn94s29r.320 h agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[disease].local:disease:cancerenrichment · researchdata tees ac ukkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:earth-environmentalmapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
descriptionsource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/description
licensesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/rights
publication_datesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
titlesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/title